Patents by Inventor Robert Uger

Robert Uger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HB-EGF Composition and Use Thereof to Treat a Condition Associated With Enhanced Urothelium Permeability
    Publication number: 20130102532
    Abstract: HB-EGF is exploited to treat conditions associated with enhanced urothelium permeability, including interstitial cystitis.
    Type: Application
    Filed: April 12, 2011
    Publication date: April 25, 2013
    Applicant: TRILLIUM THERAPEUTICS INC.
    Inventors: Robert Uger, Penka Petrova
  • Targeted immunogens
    Publication number: 20060002946
    Abstract: The present invention provides reagents and methods for producing and utilizing targeted immunogens. In preferred embodiments, an immunogen is conjugated to an amino acid sequence that targets the immunogen to the MHC presentation pathway. Using the reagents and methods provided herein, immunization protocols may be enhanced resulting in increased immunity of the host.
    Type: Application
    Filed: December 30, 2004
    Publication date: January 5, 2006
    Applicant: Aventis Pasteur, Inc.
    Inventors: William Scott Gallichan, Robert Uger, Marie-Danielle Salha